Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026)

Enovis' (ENOV) quarterly Total Non-Current Liabilities came in at $2.0 billion in Q2 2026, up 3.42% year-on-year from $1.9 billion in Q2 2025, and up 2.12% on a QoQ basis from $1.9 billion in Q4 2025.

Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Total Non-Current Liabilities data on file, last reported at $2.0 billion in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 3.42% year-over-year to $2.0 billion in Q2 2026; TTM through Apr 2026 was $2.0 billion, a 3.42% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 1.45% from the prior year.
  • Total Non-Current Liabilities for Q2 2026 stood at $2.0 billion, up from $1.9 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ENOV reached as high as $3.2 billion in Q2 2022 and fell as low as $656.5 million in Q4 2022.
  • Historically, Total Non-Current Liabilities has averaged $1.5 billion across 5 years, with a median of $1.9 billion in 2025.
  • Across the five-year window, Total Non-Current Liabilities plunged 82.41% in 2022 and soared 180.61% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $656.5 million in 2022, then surged by 34.73% to $884.5 million in 2023, then surged by 113.8% to $1.9 billion in 2024, then advanced by 1.45% to $1.9 billion in 2025, then grew by 2.12% to $2.0 billion in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $2.0 billion in Q2 2026, $1.9 billion in Q4 2025, and $2.0 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Enovis 1.50 Bn 1.47 Bn 365.49 Mn 1.96 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 1.96 Bn
Dec 31, 2025 1.92 Bn
Oct 3, 2025 1.97 Bn
Jul 4, 2025 1.99 Bn
Apr 4, 2025 1.89 Bn
Dec 31, 2024 1.89 Bn
Sep 27, 2024 1.90 Bn
Jun 28, 2024 1.90 Bn
Mar 29, 2024 1.92 Bn
Dec 31, 2023 884.46 Mn
Sep 29, 2023 799.46 Mn
Jun 30, 2023 801.24 Mn
Mar 31, 2023 683.79 Mn
Dec 31, 2022 656.46 Mn
Sep 30, 2022 905.95 Mn
Jul 1, 2022 868.01 Mn
Apr 1, 2022 3.24 Bn
Dec 31, 2021 3.73 Bn
Oct 1, 2021 2.71 Bn
Jul 2, 2021 2.61 Bn